EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The efficacy and safety of rituximab pre-treatment in allogeneic hematopoietic stem cell transplantation in pediatric patients with severe aplastic anemia

Wang Wei, Wu Jinjun, Chen Zhi, Chen Yan, Sun Ming, Lu Wenjie, Wang Zhuo, Du Yu, Qi Shanshan, Yang Li, Xiong Hao

Transplant Immunology · 2026-06 · 96 · 102376

DOI: 10.1016/j.trim.2026.102376 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplant Immunology, 2026-06. Verfasst von Wang Wei und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Oncology, Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 43001…. Hauptthemen laut MEDLINE: Rituximab, Anemia, Aplastic, Hematopoietic Stem Cell Transplantation, Herpesvirus 4, Human. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Hubei Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RituximabAnemia, AplasticHematopoietic Stem Cell TransplantationHerpesvirus 4, HumanEpstein-Barr Virus InfectionsGraft vs Host DiseaseB-LymphocytesHumansChildFemaleMaleAdolescentChild, PreschoolTransplantation, HomologousVirus ActivationInfantTreatment Outcome

Stichwörter der Autor:innen

Allogeneic hematopoietic stem cell transplantation (Allo-HSCT)Lymphocyte regenerationPediatric patientsRituximab (RTX)Severe aplastic anemia (SAA)

Substanzen

Rituximab

Autor:innen und Institutionen

  • Department of Hematology and Oncology, Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430010, China.
  • Department of Hematology and Oncology, Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430010, China. Electronic address: yangli1@zgwhfe.com.
  • Department of Hematology and Oncology, Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430010, China. Electronic address: xionghao@zgwhfe.com.

Förderung

  • Natural Science Foundation of Hubei Province

Zitieren

APA

Wei, W., Jinjun, W., Zhi, C., Yan, C., Ming, S., Wenjie, L., Zhuo, W., Yu, D., Shanshan, Q., Li, Y., & Hao, X. (2026). The efficacy and safety of rituximab pre-treatment in allogeneic hematopoietic stem cell transplantation in pediatric patients with severe aplastic anemia. Transplant Immunology, 96, 102376. https://doi.org/10.1016/j.trim.2026.102376

Vancouver

Wei W, Jinjun W, Zhi C, Yan C, Ming S, Wenjie L, et al. The efficacy and safety of rituximab pre-treatment in allogeneic hematopoietic stem cell transplantation in pediatric patients with severe aplastic anemia. Transplant Immunology. 2026;96:102376. doi:10.1016/j.trim.2026.102376

BibTeX
@article{Wei2026,
  author = {Wei, Wang and Jinjun, Wu and Zhi, Chen and Yan, Chen and Ming, Sun and Wenjie, Lu and Zhuo, Wang and Yu, Du and Shanshan, Qi and Li, Yang and Hao, Xiong},
  title = {The efficacy and safety of rituximab pre-treatment in allogeneic hematopoietic stem cell transplantation in pediatric patients with severe aplastic anemia},
  journal = {Transplant Immunology},
  year = {2026},
  volume = {96},
  pages = {102376},
  doi = {10.1016/j.trim.2026.102376}
}
Kostenlos starten →